Tesla may be getting all the headlines, but this legacy automaker is the one to watch now.
Read MoreThis retailer may have massive hit this week, but there could be double-digit upside on the horizon. Here’s why.
Read MoreThis drugmaker has a promising treatment for the virus and one expert says the stock’s technical picture makes it a buy now.
Read MoreBuy Target – $17.50 or better Sell Target – TradersPro Sell Signal Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline include XEN496, A Kv7 potassium channel modulator that is Phase II clinical trials for the treatment of KCNQ2 epilepsy; XEN1101, […]
Read MorePlus, MGM Resorts’ chairman and CEO steps down as the casino operator withdraws its financial forecast for 2020, and Pepsi and Incyte report earnings.
Read MoreWhile investors have been anxious to find reasons to shrug off fears about the economic impact of coronavirus, there are certainly some individual cases where those risks can’t really be ignored. One in the Leisure & Recreation Services industry, which includes cruise line companies. News reports of cruise ships filled with passengers that have been […]
Read More